Decreased adiposity and enhanced glucose tolerance in shikonin treated mice.
Decreased adiposity and enhanced glucose tolerance in shikonin treated mice.
复制标题
DOI:
10.1002/oby.21263
复制
发表时间:
2015-11
期刊:
影响因子:
--
通讯作者:
Haj FG
中科院分区:
文献类型:
--
作者:
Bettaieb A;Hosein E;Chahed S;Abdulaziz A;Kucera HR;Gaikwad NW;Haj FG
Obesity represents a major public health problem and identifying natural compounds that modulate energy balance and glucose homeostasis is of interest for combating obesity and its associated disorders. The naphthoquinone shikonin has diverse beneficial properties including anti-inflammatory, anti-oxidant and anti-microbial effects. The objective of this study is to investigate the effects of shikonin on adiposity and glucose homeostasis. To that end, we determined the metabolic effects of shikonin treatment on mice fed regular chow or challenged with a high fat diet (HFD). Shikonin treated mice fed regular chow exhibited improved glucose tolerance. In addition, shikonin treated mice fed HFD displayed decreased weight gain and resistance to HFD-induced glucose intolerance. Further, shikonin treatment decreased HFD-induced hepatic dyslipidemia. These findings correlated with enhanced hepatic insulin signaling in shikonin treated mice fed regular chow or HFD as evidenced by increased tyrosyl phosphorylation of the insulin receptor and enhanced downstream signaling. These studies identify shikonin as a potential regulator of systemic glucose tolerance, energy balance and adiposity in vivo.